TBWA wins three global Merck brands

Share this article:

Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.

TBWA will handle global communication strategies for each of the brands. The campaigns will debut globally in 2009, according to a company statement.

Neither company responded to inquiries about the assignment. In the statement, Hubertus von Lobenstein, CEO TBWA\Group Germany, said of the wins: “It shows the value of a great team, the international experience as well as the power of our fundamental idea: Disruption.”

Merck's global operating activities function under the umbrella Merck KGaA of Germany, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%, according to the statement. Merck & Co., the US subsidiary, became an independent company in 1917.

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.